Adding Pembrolizumab to Chemo Improves Survival in Endometrial Cancer
Addition of pembrolizumab to paclitaxel plus carboplatin yields longer progression-free survival in advanced, recurrent disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.